Acid Sphingomyelinase Deficiency (ASMD) Market Size

Market Size in USD Mn

CAGR12.3%

Study Period	2025-2032
Base Year of Estimation	2024
CAGR	12.3%
Market Concentration	High
Major Players	Sanofi, Orphazyme, Takeda Pharmaceutical, Actelion Pharmaceuticals and Among Others

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

Acid Sphingomyelinase Deficiency (ASMD) Market Analysis

The acid sphingomyelinase deficiency (ASMD) market is estimated to be valued at USD 151.2 Mn in 2025 and is expected to reach USD 340.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 12.3% from 2025 to 2032. The market is expected to showcase significant growth during the forecast period due to the rising diagnosis of ASMD and growing access to enzyme replacement therapies.